Follicular hyperplasia on the face subsequent to therapy with sorafenib. A new skin side effect

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 8, 2009, Pages 959-960

  Lopez, V ^a   Pinazo, I ^a   Marti, N ^a   Monteagudo, C ^a   Jorda, E ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; FOTEMUSTINE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR; RAF PROTEIN; SORAFENIB; TEMOZOLOMIDE; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ACRAL ERY; ACRAL ERYTHEMA; AGED; ALOPECIA; CASE REPORT; DESQUAMATION; ERYTHEMA; FATIGUE; FOLLICULAR HYPERPLASIA; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; LETTER; LUNG METASTASIS; MALE; MELANOMA; METASTASIS; METASTASIS INHIBITION; NAIL DISEASE; PRIORITY JOURNAL; RASH; STOMATITIS; SUBUNGUEAL SPLINTER HEMORRHAGE; XEROSIS;

AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BENZENESULFONATES; HUMANS; HYPERPLASIA; LUNG NEOPLASMS; MALE; MELANOMA; NITROSOUREA COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; PYRIDINES; SKIN; SKIN DISEASES; SKIN NEOPLASMS;

EID: 67651162243     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.03003.x     Document Type: Letter

References (4)

1. Wilhelm SM, Carter C, Tang L et al. BAY 43-9006 exhibits broad spectrum oral anti-tumor activity and targets the Raf/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res 2004 64 : 7099 7109.
2. Clark JW, Eder JP, Ryan D, Lathia C, Lenz HJ. Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growh factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory solid tumors. Clin Cancer Res 2005 11 : 5472 5480. (Pubitemid 41060823)
3. Lacouture ME, Desai A, Soltani K et al. Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitor. Clin Exp Dermatol 2006 31 : 783 785.
4. MacGregor JL, Silvers DN, Grossman ME, Sherman WH. Sorafenib-induced erythema multiforme. J Am Acad Dermatol 2007 March 56 : 527 528.